期刊文献+

解放军第四一一医院住院病人质子泵抑制剂使用的评价与分析 被引量:4

Evaluation and analysis of the medication of proton pump inhibitors in the patients admitted into No.411 Hospital of PLA
下载PDF
导出
摘要 目的:了解解放军第四一一医院住院病人质子泵抑制剂(proton pump inhibitors,PPIs)用药情况,促进临床合理用药。方法:利用医院信息管理系统(HIS),对2011年7月至2014年6月期间所有应用PPIs的住院病人病历进行回顾性分析。从用药适应证、用法用量和药物相互作用等方面进行合理性评判,合理性标准为药品说明书、PPIs临床应用指南。结果:该院住院病人应用PPIs的病历为14 878份,占全部病例的26.68%。应用PPIs比例较高的科室是消化内科7543份(50.70%)、烧伤整形科7412份(49.82%)。在随机抽查的527份病历中,发现不合理用药情况为:用药指征不合理占23.60%、使用疗程不合理占13.15%、用法用量不合理占33.85%、相互作用不合理占29.40%。结论:该院住院病人应用PPIs存在过度使用情况,临床选用仍应该慎重考虑,合理应用。 Objective:To investigate the medication of proton pump inhibitors(PPIs)in the patients admitted into No.411 Hospital of PLA,so as to promote rational use of PPIs clinically.Methods:Retrospective analyses were made on the medical histories of the patients admitted into the hospital for treatment from July 2011 to June 2014,by using the Hospital Information System(HIS).The rationality was analyzed by taking into consideration the indications,dosage and administration,and drug interactions.The criteria for judging rationality included packaged insert of product and standard therapeutic guidance for PPIs.Results:There were 14 878 PPI medical histories,accounting for 26.68% of all the medical histories in the hospital.The Gastroenterology Department(7543medical histories)and the Burns and Plastic Surgery Department(7412medical histories)had relatively high PPI consumption rates,accounting for 50.70% and 49.82%,respectively.In the 527 medical histories sampled at random,irrational medications of PPIs were:irrational drug indications(accounting for 23.60%),irrational treatment courses(accounting for 13.15%),irrational dosage and administration(accounting for 33.85%)and irrational drug interaction(accounting for 29.40%).Conclusion:There existed irrational utilization of PPIs in the inpatients of the hospital.A prudent policy should be adopted in the clinical utilization of PPIs and be sure to use them rationally.
出处 《药学服务与研究》 CAS 2015年第3期217-220,共4页 Pharmaceutical Care and Research
关键词 质子泵抑制剂 药物利用 合理用药 proton pump inhibitor drug utilization rational use of drugs
  • 相关文献

参考文献15

  • 1李兆申.重视应激性溃疡的规范化防治[J].世界华人消化杂志,2005,13(22):2637-2639. 被引量:88
  • 2许国铭,萧树东,李兆申,黄庭,孙永华,卢亦成,杨兴易,湛先保,赵继宗,王集生.应激性溃疡防治建议[J].中华医学杂志,2002,82(14):1000-1001. 被引量:296
  • 3Bhatt D L, Scheiman J, Abraham N S, et al. ACCF/ACG/ AHA 2008 expert consensus document on reducing the gas- trointestinal risks of antiplatelet therapy and NSAID use[J]. Am J Gastroenterol,2008,103(ll) :2890-2907.
  • 4段丹丹,李建华.我院2010年质子泵抑制剂的应用及分析[J].中国现代医药杂志,2011,13(9):43-45. 被引量:6
  • 5Yang Y X,Metz D C. Safety of proton pump inhibitor expo- sure[J]. Gastroenterology,2010,139(4) : 1115-1127.
  • 6Boparai V, Rajagopalan J, Triadafilopoulos G. Guide to the use of proton pump inhibitor in adult patients[J]. Drugs, 2008,68(7) : 925-947.
  • 7Moayyedi P, Leontiadis G I. The risks of PPI therapy[J]. Nat Rev Gastroentero| Hepatol,2012,9(3) :132-139.
  • 8Lewis J R,Barre D,Zhu K,et al. Long-term proton pump in hibitor therapy and falls and fractures in elderly women: A prospective cohort study[J]. J Bone Miner Res, 2014,29 (11) 2489-2497.
  • 9Ito T,Jensen R T. Association of long-term proton pump in- hibitor therapy with bone fractures and effects on absorption of calcium, vitamin Blz, iron, and magnesium[J]. Curr Gas troenterol Rep,2010,12(6) ~448-457.
  • 10Long A N, Atwell C L, Yoo W,et al. Vitamin BI2 deficiency associated with concomitant metformin and proton pump in hibitor use[J]. Diabetes Care, 2012,35 (12) ~ e84.

二级参考文献34

  • 1李兆申,湛先保.急性非静脉曲张性上消化道出血诊治指南(草案)[J].中华内科杂志,2005,40(1):73-76. 被引量:248
  • 2Juurlink DN,Gomes T,Ko DT,et al.Apopulation-based study of the drug interaction between proton pump inhibitors and clopidogrel[J].CMAJ,2009,180:713-718.
  • 3Ho PM,Maddox TM,Wang L,et al.Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome[J].JAMA,2009,301:937-944.
  • 4FDA. Possible increased risk of bone fractures with certain antacid drugs [ EB/OL ]. [ 2010-05-25 ]. http://www, fda. gov/ downloads/ForConsumers/ConsumerUpdates/UCM213307, pdf.
  • 5McDonagh MS, Carso S, Thakurta S. Drug Class Review: Proton Pump Inhibitors. Final Report Update5 [ EB/OL ]. ( 20094 ) [ 2012-3-15 ]. http ://derp. ohsu. edu/final/PPI_final_evidence% 20tables_update% 205_unshaded 09 MAY. pdf.
  • 6Blume H, Donath F, Warnke A, et al. Pharmacokinetic drug interaction profiles of proton pump inhibitors. Drug Saf, 2006,29: 769-784.
  • 7Horn J. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole. Aliment Pharmacol Ther,2004,20 Suppl 6 : 11-9.
  • 8FDA. Information for Healthcare Professionals: Update to the labeling of Clopidogrel Bisulfate (marketed as Plavix ) to alert heahhcare professionals about a drug interaction with omeprazole ( marketed as Prilosec and Prilosec OTC ) [ EB/OL ]. ( 2009-11 - 17 ) [ 2012-03-15 1. http://www, fda. gov/Drugs/DrugSafety/ PostmarkPatientsandProviders/DrugSafetylnformationforHeathcareProfessionals/ucm190787. htm.
  • 9Furuta T, Shirai N, Takashima M, et al. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clin Pharmacol Ther, 2001,69 : 158-168.
  • 10Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA, 2009,301:937-944.

共引文献377

同被引文献45

引证文献4

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部